The Colorectal Cancer Alliance has announced available funding for up to $1.1 million for innovative, life-saving research through its Chris4Life Research Program. Research proposals are being accepted here through Monday, March 16, 2020.
Multi-year grants will be awarded in two areas of colorectal cancer research. The Alliance will fund up to three, $300,000 grants for research into young-onset colorectal cancer and one, $200,000 grant for research into colorectal cancer health disparities. Project funding announcements will occur in Summer 2020.
Proposals will undergo a rigorous two-tier review process by members of a distinguished Scientific Review Panel, similar to the process used by the National Institutes of Health. Researchers will be required to document progress throughout the lifecycles of their grants to maintain funding.
“Our research program is a critical driving force in our mission to end colorectal cancer in our lifetime,” said Dr. Ronit Yarden, Senior Director of Medical Affairs at the Alliance.
“Since 2016, the Alliance has funded nearly $3 million in cutting edge, innovative, and life-saving research.”
While colorectal cancer incidence and mortality have been declining among adults 50 and older in recent decades, scientists are now reporting a sharp rise in colorectal cancers in adults younger than 50, an ominous trend that includes adults in their 20s and 30s.
A recent study published in the Journal of the National Cancer Institute states that adults born circa 1990, compared with those born circa 1950, have double the risk of colon cancer and quadruple the risk of rectal cancer.
Given these trends, the Colorectal Cancer Alliance’s Chris4Life Research Program is seeking research proposals in which the focus could be, but is not limited to, one or all of the following areas:
Research proposals are being accepted here until March 16, 2020.
Colorectal cancer is the second most common cancer and the second leading cause of cancer deaths among men and women combined in the United States. The distribution of both colorectal cancer incidence and mortality, however, varies among racial and ethnic groups, age, and socioeconomic status.
African Americans have the highest incidence and greatest mortality rate of any group diagnosed with colorectal cancer. Incidence and mortality are also high for American Indians/Alaskan Natives, followed by Non-Hispanic whites, Hispanics, and Asians/Pacific Islanders. Data indicate that the incidence disparity begins earlier than the typical age for colorectal screening, which is currently 50 years old.
Reasons for the disparity include healthcare access, but there are limited studies available on the impact of known risk factors. These factors include family history, lifestyle, obesity, environmental exposures, chronic stress, and genetic syndrome.
To increase the limited understanding about colorectal cancer health disparities, the Colorectal Cancer Alliance’s Chris4Life Research Program is seeking research proposals in which the focus could be, but is not limited to, one or all of the following areas:
Research proposals are being accepted here until March 16, 2020.
Discover how knowing her G12C biomarker guided Lexie’s stage IV colorectal cancer treatment — from a shock diagnosis to HIPEC surgery — and why screening, research, and self-advocacy matter.
Majority of Americans say they don’t have time for colorectal cancer screening, prioritizing household chores instead of health.
Project Cure CRC by the Colorectal Cancer Alliance is driving innovation in colorectal cancer research with $10.5 million in funding, the launch of the K-SPY clinical trial, and a renewed call for groundbreaking proposals. Learn how these efforts are accelerating treatment advancements and improving patient outcomes.